ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/04 | 2,351 | 2,408 | 2,339 | 2,379 | +37 | +1.6% | 501,900 |
| 2024/07/03 | 2,290 | 2,342 | 2,282 | 2,342 | +55 | +2.4% | 496,200 |
| 2024/07/02 | 2,350 | 2,369 | 2,279 | 2,287 | -53 | -2.3% | 751,600 |
| 2024/07/01 | 2,419 | 2,438 | 2,340 | 2,340 | -29 | -1.2% | 1,046,800 |
| 2024/06/28 | 2,450 | 2,450 | 2,352 | 2,369 | -81 | -3.3% | 787,000 |
| 2024/06/27 | 2,325 | 2,525 | 2,325 | 2,450 | +125 | +5.4% | 1,511,800 |
| 2024/06/26 | 2,371 | 2,371 | 2,303 | 2,325 | -50 | -2.1% | 609,300 |
| 2024/06/25 | 2,365 | 2,403 | 2,336 | 2,375 | +22 | +0.9% | 606,500 |
| 2024/06/24 | 2,431 | 2,466 | 2,353 | 2,353 | -107 | -4.3% | 902,900 |
| 2024/06/21 | 2,458 | 2,506 | 2,446 | 2,460 | +3 | +0.1% | 936,700 |
| 2024/06/20 | 2,350 | 2,457 | 2,346 | 2,457 | +131 | +5.6% | 1,118,000 |
| 2024/06/19 | 2,303 | 2,335 | 2,265 | 2,326 | +16 | +0.7% | 570,000 |
| 2024/06/18 | 2,376 | 2,395 | 2,305 | 2,310 | -65 | -2.7% | 943,000 |
| 2024/06/17 | 2,290 | 2,376 | 2,283 | 2,375 | +85 | +3.7% | 930,800 |
| 2024/06/14 | 2,173 | 2,323 | 2,173 | 2,290 | +67 | +3% | 768,600 |
| 2024/06/13 | 2,262 | 2,335 | 2,223 | 2,223 | -24 | -1.1% | 894,200 |
| 2024/06/12 | 2,257 | 2,283 | 2,230 | 2,247 | -6 | -0.3% | 394,100 |
| 2024/06/11 | 2,216 | 2,277 | 2,211 | 2,253 | +69 | +3.2% | 886,200 |
| 2024/06/10 | 2,158 | 2,185 | 2,115 | 2,184 | +12 | +0.6% | 618,000 |
| 2024/06/07 | 2,094 | 2,172 | 2,093 | 2,172 | +68 | +3.2% | 352,800 |
| 2024/06/06 | 2,135 | 2,146 | 2,089 | 2,104 | -19 | -0.9% | 541,800 |
| 2024/06/05 | 2,151 | 2,174 | 2,108 | 2,123 | -39 | -1.8% | 491,600 |
| 2024/06/04 | 2,156 | 2,217 | 2,127 | 2,162 | -12 | -0.6% | 661,700 |
| 2024/06/03 | 2,206 | 2,212 | 2,161 | 2,174 | -29 | -1.3% | 507,200 |
| 2024/05/31 | 2,134 | 2,256 | 2,124 | 2,203 | +86 | +4.1% | 1,297,900 |
| 2024/05/30 | 2,095 | 2,139 | 2,080 | 2,117 | +20 | +1% | 911,900 |
| 2024/05/29 | 2,120 | 2,140 | 2,068 | 2,097 | -3 | -0.1% | 660,200 |
| 2024/05/28 | 2,136 | 2,182 | 2,100 | 2,100 | +14 | +0.7% | 1,048,900 |
| 2024/05/27 | 2,071 | 2,111 | 2,030 | 2,086 | -2 | -0.1% | 854,000 |
| 2024/05/24 | 2,082 | 2,128 | 2,050 | 2,088 | -74 | -3.4% | 925,800 |
| 2024/05/23 | 2,182 | 2,203 | 2,142 | 2,162 | -5 | -0.2% | 588,900 |
| 2024/05/22 | 2,193 | 2,240 | 2,152 | 2,167 | -86 | -3.8% | 1,022,300 |
| 2024/05/21 | 2,317 | 2,344 | 2,235 | 2,253 | -94 | -4% | 1,259,400 |
| 2024/05/20 | 2,128 | 2,383 | 2,122 | 2,347 | +169 | +7.8% | 2,263,800 |
| 2024/05/17 | 2,379 | 2,380 | 2,175 | 2,178 | -245 | -10.1% | 3,416,300 |
| 2024/05/16 | 2,572 | 2,583 | 2,308 | 2,423 | +1 | ±0% | 3,196,500 |
| 2024/05/15 | 2,437 | 2,454 | 2,390 | 2,422 | -30 | -1.2% | 1,511,400 |
| 2024/05/14 | 2,395 | 2,482 | 2,393 | 2,452 | +77 | +3.2% | 911,200 |
| 2024/05/13 | 2,420 | 2,426 | 2,348 | 2,375 | -42 | -1.7% | 759,200 |
| 2024/05/10 | 2,420 | 2,462 | 2,391 | 2,417 | +23 | +1% | 754,600 |
| 2024/05/09 | 2,395 | 2,433 | 2,367 | 2,394 | -6 | -0.3% | 614,800 |
| 2024/05/08 | 2,414 | 2,503 | 2,352 | 2,400 | -14 | -0.6% | 1,288,800 |
| 2024/05/07 | 2,471 | 2,471 | 2,286 | 2,414 | -27 | -1.1% | 1,718,000 |
| 2024/05/02 | 2,406 | 2,530 | 2,401 | 2,441 | +9 | +0.4% | 938,100 |
| 2024/05/01 | 2,451 | 2,464 | 2,394 | 2,432 | -59 | -2.4% | 905,100 |
| 2024/04/30 | 2,556 | 2,577 | 2,490 | 2,491 | -19 | -0.8% | 765,500 |
| 2024/04/26 | 2,484 | 2,514 | 2,437 | 2,510 | +69 | +2.8% | 625,800 |
| 2024/04/25 | 2,461 | 2,468 | 2,422 | 2,441 | -49 | -2% | 504,500 |
| 2024/04/24 | 2,520 | 2,542 | 2,490 | 2,490 | +6 | +0.2% | 410,400 |
| 2024/04/23 | 2,500 | 2,547 | 2,475 | 2,484 | -1 | ±0% | 605,500 |
201～
250
件表示中 / 3691件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | - | +21.7% | +999.9% | - | - | - |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | - | +15.0% | -7.3% | - | - | - |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | - | +14.2% | +41.0% | - | - | - |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | - | +3.0% | +27.5% | - | - | - |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | - | +8.8% | +99.9% | - | - | - |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
